Hjem › Brystkreft › Virginia › Charlottesville
Kliniske studier for Brystkreft i Charlottesville, VA
9 studier for Brystkreft søker deltakere på steder i og rundt Charlottesville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Sentara Martha Jefferson Hospital, Charlottesville
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruttererFase 3
- Research Site, Charlottesville
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
RekruttererFase 2
- University of Virginia Health System, Charlottesville
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- University of Virginia Cancer Center, Charlottesville
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
RekruttererFrivillige helsepersonell ønskes velkommen
- University of Virginia, Charlottesville
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
RekruttererFase 3
- University of Virginia, Charlottesville
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
RekruttererFase 1/2
- University of Virginia, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Charlottesville
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
RekruttererFase 2/3
- University of Virginia, Charlottesville
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Charlottesville
- Ikke-småcellet lungekreft21 studier
- Akut myelogen leukemi16 studier
- Prostatakreft15 studier
- Kreft (alle typer)13 studier
- Endometriekreft13 studier
- Metastatisk kreft13 studier
- Lungekreft13 studier
- Hjertesvikt12 studier
- Kolorektal kreft10 studier
- Eggstokkreft10 studier
- Type 1-diabetes9 studier
- Pankreaskreft9 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.